tiprankstipranks
Advertisement

SMOT - ETF AI Analysis

Compare

Top Page

SMOT

VanEck Morningstar SMID Moat ETF (SMOT)

Rating:68Neutral
Price Target:
SMOT, the VanEck Morningstar SMID Moat ETF, earns a solid overall rating largely because several core holdings like Royalty Pharma, Corteva, and Stifel Financial show strong financial performance, positive earnings calls, and strategic growth initiatives that support future expansion. At the same time, weaker names such as Masco, with mixed financials and bearish trading signals, and holdings facing high valuations or leverage issues, slightly weigh on the fund’s appeal. The main risk factor is that many top positions share concerns around rich valuations and some bearish or mixed technical trends, which could increase volatility if market sentiment turns.
Positive Factors
Strong Top Holdings Performance
Many of the largest positions have shown strong gains so far this year, helping support the ETF’s overall results.
Broad Sector Diversification
The fund spreads its investments across many different sectors, which can help reduce the impact if any one industry struggles.
Healthy Asset Base
The ETF manages a sizable pool of assets, which can support trading liquidity and ongoing fund stability for investors.
Negative Factors
High U.S. Concentration
Almost all of the ETF’s holdings are in U.S. companies, offering very little geographic diversification outside the United States.
Moderate Expense Ratio
The fund’s fee is not especially low, which means costs may eat into returns more than with some cheaper index ETFs.
Recent Short-Term Volatility
The ETF’s recent three-month performance has been weak compared with its stronger one-month and year-to-date results, suggesting some short-term ups and downs.

SMOT vs. SPDR S&P 500 ETF (SPY)

SMOT Summary

SMOT is the VanEck Morningstar SMID Moat ETF, which follows the Morningstar US Small-Mid Cap Moat Focus Index. It invests mainly in U.S. small and mid-sized companies that Morningstar believes have strong competitive advantages, or “moats.” The fund spreads money across many sectors, including health care, technology, and industrials, and holds well-known names like Airbnb and Zoom. Someone might invest in SMOT to seek long-term growth and diversify beyond large, well-known stocks. A key risk is that smaller companies can be more volatile, so the share price can move up and down more than the overall market.
How much will it cost me?The VanEck Morningstar SMID Moat ETF (Ticker: SMOT) has an expense ratio of 0.49%, meaning you’ll pay $4.90 per year for every $1,000 invested. This is slightly higher than average for ETFs because it is actively managed, focusing on identifying companies with strong competitive advantages or 'moats.'
What would affect this ETF?The VanEck Morningstar SMID Moat ETF could benefit from economic growth and innovation in sectors like technology and consumer cyclical, which make up a significant portion of its holdings. However, it may face challenges if interest rates rise, as smaller companies often struggle with higher borrowing costs, or if economic uncertainty impacts consumer spending. Its focus on U.S. small and mid-cap stocks provides growth potential but also exposes it to volatility compared to large-cap investments.

SMOT Top 10 Holdings

SMOT leans heavily into U.S. small and mid-cap names with solid “moats,” and its story right now is driven by a mix of health care, industrial, and consumer plays. Royalty Pharma and Biogen are rising steady-eddies in biotech, helping anchor returns, while Corteva adds a steady agricultural tilt. On the consumer side, Masco and Brown-Forman are quietly climbing, but the cruise lines—Carnival and Norwegian—are more of a roller coaster, occasionally dragging on performance. Overall, the fund is diversified by sector but still very U.S.-centric.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Bio-Techne1.67%$5.51M$11.15B38.02%
64
Neutral
Block1.49%$4.93M$47.61B18.51%
72
Outperform
Masco1.49%$4.90M$15.71B20.10%
53
Neutral
Acuity Brands1.47%$4.85M$9.80B16.53%
77
Outperform
IQVIA Holdings1.47%$4.84M$34.69B30.36%
73
Outperform
Royalty Pharma1.44%$4.74M$32.06B58.17%
79
Outperform
Corteva1.42%$4.68M$56.79B15.72%
75
Outperform
Cigna1.39%$4.57M$80.25B-2.62%
72
Outperform
Airbnb1.38%$4.55M$88.32B8.54%
71
Outperform
Stifel Financial1.37%$4.51M$11.71B9.83%
75
Outperform

SMOT Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
38.33
Positive
100DMA
37.21
Positive
200DMA
36.71
Positive
Market Momentum
MACD
0.29
Positive
RSI
61.80
Neutral
STOCH
58.76
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For SMOT, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 38.91, equal to the 50-day MA of 38.33, and equal to the 200-day MA of 36.71, indicating a bullish trend. The MACD of 0.29 indicates Positive momentum. The RSI at 61.80 is Neutral, neither overbought nor oversold. The STOCH value of 58.76 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SMOT.

SMOT Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$330.01M0.49%
68
Neutral
$756.06M0.75%
68
Neutral
$721.04M0.62%
64
Neutral
$495.35M0.75%
71
Outperform
$328.03M0.53%
64
Neutral
$285.36M0.55%
68
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SMOT
VanEck Morningstar SMID Moat ETF
39.59
4.58
13.08%
RSMC
Rockefeller U.S. Small-Mid Cap ETF
MSSM
Morgan Stanley Pathway Small-Mid Cap Equity ETF
GRNJ
Fundstrat Granny Shots US Small- & Mid-Cap ETF
ISMD
Inspire Small/Mid Cap Impact ETF
SMIZ
Zacks Small/Mid Cap ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement